BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang L, Balmat TJ, Antonia AL, Constantine FJ, Henao R, Burke TW, Ingham A, McClain MT, Tsalik EL, Ko ER, Ginsburg GS, DeLong MR, Shen X, Woods CW, Hauser ER, Ko DC. An atlas connecting shared genetic architecture of human diseases and molecular phenotypes provides insight into COVID-19 susceptibility. medRxiv 2020:2020. [PMID: 33398303 DOI: 10.1101/2020.12.20.20248572] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Mehboob F, Rauf A, Jiang R, Saudagar AKJ, Malik KM, Khan MB, Hasnat MHA, AlTameem A, AlKhathami M. Towards robust diagnosis of COVID-19 using vision self-attention transformer. Sci Rep 2022;12:8922. [PMID: 35618740 DOI: 10.1038/s41598-022-13039-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Nikolaou M. Revisiting the standard for modeling the spread of infectious diseases. Sci Rep 2022;12:7077. [PMID: 35490159 DOI: 10.1038/s41598-022-10185-0] [Reference Citation Analysis]
3 Boutin S, Hildebrand D, Boulant S, Kreuter M, Rüter J, Pallerla SR, Velavan TP, Nurjadi D. Host factors facilitating SARS-CoV-2 virus infection and replication in the lungs. Cell Mol Life Sci 2021;78:5953-76. [PMID: 34223911 DOI: 10.1007/s00018-021-03889-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Welcome MO, Mastorakis NE. Neuropathophysiology of coronavirus disease 2019: neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2 infection. Inflammopharmacology 2021;29:939-63. [PMID: 33822324 DOI: 10.1007/s10787-021-00806-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
5 McKinley SK, Singh P, Yin K, Wang J, Zhou J, Bao Y, Wu M, Pathak K, Mullen JT, Braun D, Hughes KS. Disease spectrum of gastric cancer susceptibility genes. Med Oncol 2021;38:46. [PMID: 33760988 DOI: 10.1007/s12032-021-01495-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Amere Subbarao S. Cancer vs. SARS-CoV-2 induced inflammation, overlapping functions, and pharmacological targeting. Inflammopharmacology 2021;29:343-66. [PMID: 33723711 DOI: 10.1007/s10787-021-00796-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
7 Carvalho T, Krammer F, Iwasaki A. The first 12 months of COVID-19: a timeline of immunological insights. Nat Rev Immunol 2021;21:245-56. [PMID: 33723416 DOI: 10.1038/s41577-021-00522-1] [Cited by in Crossref: 57] [Cited by in F6Publishing: 136] [Article Influence: 57.0] [Reference Citation Analysis]
8 Pitre T, Jones A, Su J, Helmeczi W, Xu G, Lee C, Shamsuddin A, Mir A, MacGregor S, Duong M, Ho T, Beauchamp MK, Costa AP, Kruisselbrink R; COREG Investigators. Inflammatory biomarkers as independent prognosticators of 28-day mortality for COVID-19 patients admitted to general medicine or ICU wards: a retrospective cohort study. Intern Emerg Med 2021;16:1573-82. [PMID: 33496923 DOI: 10.1007/s11739-021-02637-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
9 Qiu J, Peng S, Yin J, Wang J, Jiang J, Li Z, Song H, Zhang W. A Radiomics Signature to Quantitatively Analyze COVID-19-Infected Pulmonary Lesions. Interdiscip Sci 2021;13:61-72. [PMID: 33411162 DOI: 10.1007/s12539-020-00410-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
10 Singh A, Gupta V. SARS-CoV-2 therapeutics: how far do we stand from a remedy? Pharmacol Rep 2021;73:750-68. [PMID: 33389724 DOI: 10.1007/s43440-020-00204-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
11 Laurenge A, Ursu R, Houillier C, Abdi B, Tebano G, Quemeneur C, Choquet S, Di Blasi R, Lozano F, Morales A, Durán-Peña A, Sirven-Villaros L, Mathon B, Mokhtari K, Bielle F, Martin-Duverneuil N, Delattre JY, Marcelin AG, Pourcher V, Alentorn A, Idbaih A, Carpentier AF, Leblond V, Hoang-Xuan K, Touat M. SARS-CoV-2 infection in patients with primary central nervous system lymphoma. J Neurol 2021;268:3072-80. [PMID: 33387015 DOI: 10.1007/s00415-020-10311-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 Di Domenico SL, Coen D, Bergamaschi M, Albertini V, Ghezzi L, Cazzaniga MM, Tombini V, Colombo R, Capsoni N, Coen T, Cazzola KB, Di Fiore M, Angaroni L, Strozzi MA. Clinical characteristics and respiratory support of 310 COVID-19 patients, diagnosed at the emergency room: a single-center retrospective study. Intern Emerg Med 2021;16:1051-60. [PMID: 33175297 DOI: 10.1007/s11739-020-02548-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]